Strategies for disease-specific programmes 2010–2013
This document sets out the strategic priorities for all six ECDC disease-specific programmes from 2010 to 2013 based on a short description of the epidemiological background, context in which ECDC works on that specific disease or disease group, and defined gaps that require action at the European Union (EU) level.
Zika virus and safety of substances of human origin: a guide for preparedness activities in Europe – first update
This first update of the original guide was prompted by the evolution of the Zika virus epidemic, a new classification system for countries/areas, and recent scientific developments.
Scientific advice on type F botulism
This report analyses the availability and effectiveness of different types of antitoxins to neutralise type F botulism. A literature review was performed in consultation with the European Medicines Agency.
Technical guidance on risk assessment guidelines for diseases transmitted on aircraft (RAGIDA). Part 2: Operational guidelines - Second edition
In the closed cabin environment of modern airplanes, passengers are frequently exposed to various infectious diseases.
Options for preparing for gatherings in the EU in the context of the current outbreak of EVD in West Africa
This document outlines preparedness options with respect to gatherings with participants that have had possible exposure to Ebola virus.
ECDC policy briefing - Preparing for Zika in the EU
This document highlights preparedness measures that should be in place to minimise the risk of Zika virus spreading in continental Europe, primarily to protect pregnant women and women who wish to become pregnant, considering the evidence of the association between Zika virus and congenital malformations of the brain of the developing foetus.
Zika virus and safety of substances of human origin – A guide for preparedness activities in Europe
This document includes key elements to be considered in the risk-based decision-making process of mitigating the threats to the safety of substances of human origin posed by Zika virus.